Here's a link to the full WHO report (which looks back to January 2022, as well as breaks down data, by province -- inside the DRC, and elsewhere, into very informative "heatmaps" like the country-wide data at right) -- but here are the most salient bits, for the moment:
. . .In 2024, and as of 22 September, 15 countries in Africa have reported 6603 confirmed Mpox cases, including 32 deaths (case fatality ratio [CFR] among confirmed cases of 0.5%). In the last week 402 new confirmed cases and no new deaths were reported. The three countries reporting the most cases in 2024 are the Democratic Republic of the Congo (5621 confirmed cases, 25 deaths), Burundi (696 confirmed cases, no deaths), and Nigeria (78 confirmed cases, no deaths).
In addition to the Democratic Republic of the Congo, deaths among confirmed Mpox cases in 2024 have been reported in South Africa (three), Cameroon (two), Central African Republic (one) and Cote d’Ivoire (one).
Among the countries reporting mpox in 2024, all 15 countries have reported new confirmed cases within the past six weeks (as at right). . . .
The six weeks measure mentioned above means to suggest that the outbreak is ongoing, as no pair of six weeks periods in any affected nation. . . has returned no new cases. That is the gold standard for arresting an Mpox Clade Ib outbreak: traversing two six week periods -- without a new case -- from the last new case.
Now you know -- onward, despite very trying epidemiological times in central Africa. Onward.
नमस्ते
No comments:
Post a Comment